Welch & Forbes LLC Dexcom Inc Transaction History

Welch & Forbes LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$86.06 - $137.93 $16,437 - $26,344	-191 Reduced 4.72%	3,857 $359,000
Q2 2023 Jul 28, 2023	BUY	$112.47 - $130.98 $5,398 - $6,287	48 Added 1.2%	4,048 $520,000
Q1 2023 Apr 14, 2023	SELL	$104.0 - $122.92 $61,984 - $73,260	-596 Reduced 12.97%	4,000 $464,000
Q3 2022 Oct 28, 2022	BUY	$76.35 - $94.18 $14,964 - $18,459	196 Added 4.45%	4,596 $370,000
Q2 2022 Jul 22, 2022	BUY	$67.99 - $132.89 $224,366 - $438,536	3,300 Added 300.0%	4,400 $328,000
Q1 2022 Apr 25, 2022	SELL	$94.08 - $130.2 $75,264 - $104,159	-800 Reduced 42.11%	1,100 $563,000
Q1 2021 Apr 14, 2021	SELL	$84.79 - $104.74 $42,395 - $52,370	-500 Reduced 20.83%	1,900 $683,000
Q4 2020 Jan 20, 2021	BUY	$78.0 - $104.5 $187,200 - $250,800	2,400 New	2,400 $887,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Welch & Forbes LLC, based on Form 13F filings with the SEC.

Stay updated on Welch & Forbes LLC with notifications on news.